US loss of exclusivity · Immunology

Taltz

Eli Lilly

2030US biosimilars from
2025Today: 20262037
2025 worldwide sales
$3.6B
Date basis
Company guidance
US biosimilars
In clinical trials
Pharma Patent Cliff by readouts.io Data checked 24 October 2026 · Full Taltz timeline →